Indications for Treatment of Hypocalcemia
Treatment of hypocalcemia is indicated as an emergency when hypocalcemia is severe or when clinically significant neurologic or upper-airway symptoms are present. Severe hypocalcemia is typically treated with intravenous calcium when total serum calcium is usually <7.5 mg/dL. [1]
Treatment Indication Based on Calcium Severity
Intravenous calcium treatment is indicated for severe hypocalcemia, typically defined as total serum calcium usually <7.5 mg/dL. [1]
Treatment Indication Based on Symptoms
Intravenous calcium treatment is indicated when hypocalcemia presents with neurologic manifestations. [1]
Intravenous calcium treatment is indicated when hypocalcemia presents with stridor (laryngo/bronchospasm). [1]
Route and Timing of Calcium Replacement
Intravenous calcium should be administered when intravenous therapy is indicated for acute hypocalcemia. [1]
Calcium gluconate should be given as intravenous slow pushes, generally one vial over ~10 minutes, with electrocardiographic monitoring, for acute treatment. [1]
A chronic intravenous drip should be started if the patient remains symptomatic and oral therapy cannot act rapidly enough. [1]
Monitoring During Acute Treatment
Calcium replacement should be guided by signs, symptoms, and repeat calcium measurements every 1–2 hours, preferably using ionized calcium levels. [1]
Transition to Chronic Therapy
Oral calcium (for example, 1–2 g elemental calcium) and a rapidly acting vitamin D preparation (for example, calcitriol 0.5–1.0 mcg in divided doses) should be started as soon as practical after acute stabilization. [1]
Chronic therapy aims to keep the patient free of symptoms and maintain serum calcium at approximately 8.0–9.0 mg/dL. [1]
Clinical Nuance for Persisting Symptoms
Lower serum calcium levels can be associated with persistent symptoms over time even after initial management. [1]
Special Contributor That Can Require Concurrent Treatment
Magnesium deficiency should be treated when present because it can attenuate the effect of calcium and vitamin D therapy. [1]
Target Goals of Therapy
The chronic goal is symptom control with serum calcium maintained at approximately 8.0–9.0 mg/dL. [1]